The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The primary goal of this project is to describe the clinical and physiologic characteristics of Spontaneous Coronary Artery Dissections (SCAD) in order to increase awareness, understanding, treatment and prevention of a potentially fatal cardiovascular event.
This study will be a retrospective and prospective review of medical course and current health of men and women with SCAD.
Eligibility criteria
Qualifiers
Individuals who have been cared for at Mayo Clinic with a diagnosis of SCAD
SCAD in women who are pregnant or within 12 months postpartum at the time of SCAD
SCAD in individuals who self-identify as a member of a racial or ethnic group that is currently underrepresented in the registry. This would include anyone who identifies as: Black/African American, Asian, American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, and any race with Hispanic ethnicity
SCAD in a man
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov